4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-053766
Chief Scientific Officer sold 11,685 shares at an average $34.25 ($400,231)
- Chief Scientific Officer acquired 11,685 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
ROBINS HARLAN S · Chief Scientific Officer
Table I: Non-derivative
7 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-25 | Exercise or conversion : show line 1 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-08-25 | Sale : show line 2 in the form | −3,895 | $34.09 | $132,781 | 69,360 | D |
| 2021-08-26 | Exercise or conversion : show line 3 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-08-26 | Sale : show line 4 in the form | −3,895 | $33.89 | $132,002 | 69,360 | D |
| 2021-08-27 | Exercise or conversion : show line 5 in the form | +3,895 | $6.32 | $24,616 | 73,255 | D |
| 2021-08-27 | Sale : show line 6 in the form | −961 | $34.18 | $32,847 | 72,294 | D |
| 2021-08-27 | Sale : show line 7 in the form | −2,934 | $34.97 | $102,602 | 69,360 | D |
| Open-market sales · 11,685 sh · avg $34.25 · $400,231 | ||||||
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-08-25 | Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) | −3,895 | 101,270 | D |
| 2021-08-26 | Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) | −3,895 | 97,375 | D |
| 2021-08-27 | Exercise or conversion : show line 10 in the form Stock Option (Right to Buy) | −3,895 | 93,480 | D |
Loading xslF345X03/doc4.xml…